Compare Ecopetrol SA (EC) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ecopetrol SA vs TransMedics Group Inc — how do they compare? Ecopetrol SA trades at $17.01 (market cap $33.69B), while TransMedics Group Inc trades at $86.41 (market cap $3.10B). The key difference: Ecopetrol SA is far larger — about 10.9× TransMedics Group Inc's market cap, and Ecopetrol SA pays a 3.82% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals.
| EC | TMDX | |
|---|---|---|
Market Cap | $33.69B | $3.10B |
Sector | Energy | Technology |
52-Week High | $17.40 | $150.42 |
52-Week Low | $8.56 | $61.99 |
Enterprise Value | $63.86B | $3.49B |
Dividend Yield | 3.82% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Ecopetrol (EC) trades at $17.05, up 1.61% with a bullish technical signal from moving averages. The company reported mixed Q2 2026 earnings, beating EPS estimates but showing declining revenue trends from $119.69T in 2025 to $116.95T projected for 2026. Recent developments include a cybersecurity incident in July 2026 and ongoing acquisition activities in Brazil's energy sector through Brava Energia.
The stock presents a value opportunity with attractive valuation ratios (P/E 11.11, P/S 0.97) but faces headwinds from declining revenue and profit margins. Analyst consensus is cautious with a $15 price target below current levels, while institutional sentiment shows mixed ratings amid operational challenges and cybersecurity risks.
TransMedics Group (TMDX) trades at $86.43, down 2.24% amid recent earnings misses but maintains strong analyst support with a $99.57 consensus target. The stock shows bullish technical signals with support at $84-87, though RSI levels suggest overbought conditions. Fundamentally, the company demonstrates robust profitability with 58.69% gross margins and 22.69% net income margins, despite recent quarterly earnings falling short of expectations.
Investment outlook remains positive given strong institutional backing and growth potential in organ transplant technology, though risks include ongoing fiduciary investigations and margin pressure from increased operating costs. The stock offers 15% upside to consensus targets but requires monitoring of Q3 earnings performance and legal developments.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ecopetrol SA
Ecopetrol SA is a vertically integrated oil company with operations in Latin America and the United States Gulf Coast. Based out of Colombia, the company explores, develops, and conducts production activities in various countries. Ecopetrol works as the primary operator or partner in a joint venture, in a host of assets held onshore and offshore. Along with production, the company refines and markets crude oils and byproducts produced from its fields. Crude products are moved by Ecopetrol through a series of pipelines throughout Colombia, along with a network of third-party production centers and facilities.
Read more on EC →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
